Companies covered: Abbott Laboratories (NYSE:ABT), Illumina, Inc. (NASDAQ:ILMN), Alere Inc. (NYSE:ALR), Agilent Technologies, Inc. (NYSE:A), Bruker Corporation (NASDAQ:BRKR), Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corporation (NYSE:DHR), NanoString Technologies, Inc. (NASDAQ:NSTG), Genomic Health, Inc. (NASDAQ:GHDX), Stryker Corporation (NYSE:SYK), Teleflex Incorporated (NYSE:TFX), Zimmer Holdings, Inc. (NYSE:ZMH), Smith & Nephew SNATS, Inc. (NYSE:SNN), NuVasive, Inc. (NASDAQ:NUVA), Globus Medical, Inc. (NYSE:GMED), Accuray Incorporated (NASDAQ:ARAY), Medtronic, Inc. (NYSE:MDT), Varian Medical Systems, Inc. (NYSE:VAR), LeMaitre Vascular, Inc. (NASDAQ:LMAT), MiMedx Group, Inc (NASDAQ:MDXG), Johnson & Johnson (NYSE:JNJ), EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS), Soligenix, Inc. (OTCBB:SNGX), Protea Biosciences Group, Inc. (OTCBB:PRGB), AmpliPhi Biosciences Corporation (NYSEMKT:APHB), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), CombiMatrix Corporation (NASDAQ:CBMX), DBV Technologies S.A. (NASDAQ:DBVT), Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), United Cannabis Corporation (OTCBB:CNAB)
